4/05

CURRICULUM VITAE
University of Missouri (Columbia), M.D., 1971 St. Louis Jewish Hospital (Medicine), 1972 Barnes Hospital/Washington University Medical School(Neurology, 1972-1975) American Board of Psychiatry & Neurology, 1977 PRACTICE EXPERIENCE
Attending Neurologist, Eastern Maine Medical Center, Bangor, Maine, 1975-1980 Consulting Neurologist, Mt. Desert Island Hospital, Bar Harbor, Maine, 1975-1980 Consulting Neurologist, Penobscot Bay Medical Center, Camden, Maine, 1976-1980 Consulting Neurologist, Muscular Dystrophy Association Clinic, Bangor, Maine, 1979-1980 Private Practice, Phoenix Neurological Associates, February 1981 to present Attending Neurologist, Good Samaritan Regional Medical Center, 1981 to present Co-Director, EEG Laboratory, Good Samaritan Regional Medical Center, 1981 to present Co-Director, EEG Laboratory, Phoenix Baptist Hospital, 1981 to 1992 SOCIETIES
Maine Neurological SocietyMaricopa County Medical Society Arizona Society of Neuroimaging, CertifiedAmerican Medical Association Board of Directors, Regional Learning Center. Bangor, Maine, 1977-1979 MEDICAL LICENSES
Diplomate, American Board of Medical Examiners, July 1972Maine License #802, issued April 1975 Arizona License #12497, issued January 1981 APPOINTMENTS
Chairman, Residency Education Advisory Committee, Phoenix Baptist Hospital, 1986-1987 Chairman, Search Committee for Chief of Family Practice Residency, Phoenix Baptist Hospital, Chairman, Maricopa County Medical Society AIDS Task Force, 1987-1990 Alternate Delegate, Arizona Medical Association, 1989 Nominee, Arizona Medical Association Delegate to AMA, 1989 Search Committee, Good Samaritan Regional Medical Center, Chief Executive Officer, 1992 Chairman, Department of Medicine, Good Samaritan Regional Medical Center, 1992-1993 Executive Committee, Good Samaritan Regional Medical Center, 1992-1993 Board Examiner, American Board of Psychiatry & Neurology, 1993 – Vice Chairman, Department of Medicine, Good Samaritan Regional Medical Center,1994-2003 Co-Chief, Section of Neurology, Good Samaritan Regional Medical Center, 1998- Co-Director, Stroke Center, Good Samaritan Regional Medical Center, 1999-2003 Medical Director, Cypress Health Care Services, 1996-1997 Secretary-Treasurer, Medical Staff, Good Samaritan Regional Medical Center, 2001-2003 Vice Chief of Staff, Good Samaritan Regional Medical Center, 2003 - 2004 Chief of Staff, Good Samaritan Regional Medical Center, 2005 - PRESENTATIONS
Treatment of Stroke, Good Samaritan Neurology Seminar, 1986 Neurologic Complications of AIDS, ARMA Meeting, 1987 Update on Headache, Critical Issues in Medicine Course, 1996 Update on Epilepsy, Critical Issues in Medicine Course, 1997 Update on Stroke, Critical Issues in Medicine Course, 1998 What' New in Neurology, American College of Physicians, 2000 Update on Stroke, Southwest Hispanic-American Physicians Meeting, 2004 TEACHING APPOINTMENTS
Good Samaritan Regional Medical Center Residency Program, 1981 to present BNI Neurology Residency Program, 1986 to present University of Arizona, Associate Clinical Professor of Neurology, 1996 to present PUBLICATIONS
Tamm, Nolph and Maher: Factors Affecting Plasma Calcium During Hemodialysis. Arch Tamm and Nolph: Factors Affecting Ultrafiltrable Calcium. Clinical Research 12: 1, January 1971 Tamm and Long: CT Scanning in Maine: Initial Clinical Experience. Journal Maine Medical Tamm, Hendin, Yudell and Guidry: Coccidioidal Meningitis Narcotic Using Amphotericin B Therapy. Arch Internal Medicine 148, 1988 Tamm: Obstetric Intensive Care: A Practical Manual. Chapter entitled "Neurologic Emergencies During Pregnancy." Editors Foley & Strong, Published by WB Saunders, 1997 RESEARCH PROTOCOLS
Protocol #E301. DHE-45 Nasal Spray for headache Protocol #2GHBA-903. Sumatriptan for headacheProtocol #IX-1 01-022. IV Nalmefene for stroke Protocol #303. Mentane HP 029 for Alzheimer's diseaseProtocol #945-090. Gabapentin for epileptic seizures Protocol #979-7. C1979 for Alzheimer's diseaseProtocol #VGPROO98. Sabril for epileptic seizures Protocol #VGPRO 101. Sabril for epileptic seizuresProtocol #LUB-IN-9. Lubeluzole for stroke Protocol #IX-103-002. Nalmefene for strokeProtocol #BMS 1 80048. CN I 1 5-025 for 'Migraine Protocol #M92-825. Tiagabine for epileptic seizuresProtocol #GBHA. Eldepryl for Parkinson's disease Protocol #S2WA3001. Naratriptan for migraineProtocol #IX-104-002. Nalmefene for stroke Protocol #982-25-045. Fosphenytoin for strokeProtocol #SB202026. 202026 for Alzheimer's disease Protocol #945-000-213. Neurontin for seizuresProtocol #945-21 7. Neurontin for migraine Protocol #SB220453. 220453 for migraineProtocol #1 05-133. Lamictal for seizures Protocol #LUB-USA-6. Lubeluzole for stroke Protocol #3062KI-200-US. Fiblast for strokeProtocol #52WA4002. Naratriptan for migraine Protocol #202026/050 for Alzheimer's diseaseProtocol #1008-009/010. Pregabalin for seizures Protocol #CN 1 23-01 1. IV BMS 204352 for strokeProtocol #IP302-0 1 6. Citocoline for stroke Protocol #1008-032/033. Pregabalin for low back painProtocol #981-124 Atorvastatin for stroke/TIA Protocol #AST02. ICOS HALT for strokeProtocol #30006. Lamictal comparison/menstrual abnormalities Protocol #0101. Rufinamide for seizuresProtocol #PRI- TOP-IN-28. Topamax for seizures Protocol #ELET -071. Eletriptan for migraineProtocol #GL Y-30011. GAIN-ASIST for stroke Protocol #LAM40091. Lamictal for seizuresProtocol #S2W40027. Naratriptan for menstrual migraine Protocol #872CLO03. ARTIST MRI for stokeProtocol #872CLO04. ARTIST + for stroke Protocol #CCM9981 A04. Comtan for Parkinson's diseaseProtocol #BMS IM101-200 for multiple sclerosis Protocol #Biogen C1802 for multiple sclerosisProtocol #Astra Zeneca 311CVS/0022. Zomig Nasal Spray Protocol #SUM40299. Imitrex for migraine headachesProtocol #Charisma EFC4505. Plavix vs aspirin Protocol #Fujisawa FK 506 for stroke.
Protocol #XRP4563H/4001. Lovenox for stroke Protocol #GSK 249417 for strokeProtocol #GSK LAM40112. Lamictal for cognition Protocol #GSK LAM40124. Lamictal for behaviorProtocol #Ilex-Campath for MS Protocol #Berlex/MDS - MS studyProtocol #Biogen 1808 for multiple sclerosis Protocol #Genentech. Rituxan for dermatomyositisProtocol #ACT. Avonex/steroids for multiple sclerosis Protocol #TEVA 9013 for MSProtocol #Teva NC100 for MS Protocol #Pfizer. Implement study for MSProtocol #Genentech U2787g for MS Protocol #Glaxo 101468/228 for Parkinson’s diseaseProtocol #Glaxo LAM100034 for partial seizure Protocol #Glaxo LAM100036 for generalized seizureProtocol #Ortho McNeil CAPSS272 for seizure Protocol #Glaxo 49653/461 for Alzheimer’sProtocol #Johnson & Johnson 333369EPY2003 for seizure Protocol #Genentech - RIM study for dermatomyositisProtocol #Boehringer-Ingelheim - PROFESS for post-stroke Protocol #Teva. TNC GA MS 2004 01 ASSERT for MSProtocol # Columbia University Selection for ALS Protocol #T-GEN for ALSProtocol #Teva PM028. NABS for MS Protocol #Weintraub. Palm Mag Device for Diabetic NeuropathyProtocol #Biogen. Strata for MS Protocol #Lilly HMDY for diabetic neuropathyProtocol #Lilly F1J-US-HMEZ for diabetic neuropathy Protocol #GSK AVA104617 for Alzheimer’s diseaseProtocol #Novartis FTY720D 2302 for MS Protocol #Biogen 101MS 102 for MSProtocol #Biogen 109 MS 301 for MS Protocol #Lilly. Small fiber neuropathyProtocol #BIOMS MBP8298-SP--03 for secondary progressive MS Protocol # Biogen 101MS 402 for MSProtocol #Teva Bravo for MS Protocol #Lilly HMEF for MSProtocol #Merck Musi Qo1 for MS Protocol #Roche/Genentech olcrizimab for MSProtocol #Medimmune CP 151 for dermatomyositis/polymyositis Protocol #David Saperstein. Lithium for inclusion body myositisProtocol #Cytex. Arimoclomol for ALS Protocol #Mass General. Ceftriaxone for ALSProtocol #T-GEN. Tretinoin for ALS Protocol #Schering-Plough TIMI 50 for post-strokeProtocol #Genzyme MTAP. Myozyme for Pompe Protocol #J&J 333369 NPP 2002 for diabetic peripheral neuropathy

Source: http://www.phoenixneurology.com/cv/Tamm.pdf